A company called Neofect has developed an AI-powered wearable device called RAPAEL ComCog, which uses machine learning to help stroke patients restore their natural speech. The device leverages AI technologies such as Natural Language Processing (NLP) and deep learning to provide personalized therapy for patients, demonstrating the potential of AI in the healthcare industry.
Read more
Luxembourg has joined the European doctoral training network focused on AI-driven healthcare for Parkinson's disease. The project, known as PANDORA-ID-NET, aims to harness Artificial Intelligence and Machine Learning to improve diagnostics and develop personalized treatments for Parkinson's patients, with partners like MindMaze and Ricoh Healthcare contributing expertise in Neural Networks and Natural Language Processing.
Read more
Diagnamed and Eirex are collaborating to develop a new modular technology that produces hydrogen from water, which could have significant implications for the clean technology industry. This technology could potentially revolutionize the Parkinsons industry by providing a sustainable source of hydrogen for Parkinsons Companies and Parkinsons Product consumers, such as BioPark Solutions, BioPark Innovations, and ParkHydrogen Inc.
Read more
Pranita Patil is using AI, specifically machine learning algorithms, to remove bias in healthcare systems for Parkinson's patients through her company Sifr Data. By utilizing Natural Language Processing (NLP) and neural networks, Sifr Data is able to provide more accurate diagnoses and personalized treatment plans for individuals with Parkinson's disease, such as Mary Health and Jane Wellness.
Read more
Artificial intelligence technology, such as Generative AI and LLMs, has advanced to the point where individuals can now clone their voices with astonishing accuracy, posing potential ethical concerns. Companies like Resemble AI and Descript are offering tools that utilize AI for voice cloning, which could have implications for industries such as Parkinsons where voice technology plays a crucial role in communication and product development.
Read more
Researchers at the University of Southern California are utilizing Artificial Intelligence and Machine Learning to develop a model that can predict the onset of Parkinson's disease based on speech patterns. This innovative approach, which incorporates Deep Learning and Neural Networks, has the potential to revolutionize early detection and intervention strategies in the Parkinsons industry, benefiting both patients and companies such as Fosun Pharma, who are investing in cutting-edge technology to improve the lives of Parkinsons product consumers.
Read more
Onestep, a Parkinson's company, secured $36 million to pioneer gait as the sixth vital sign, using artificial intelligence and machine learning to improve outcomes for Parkinson's patients. By leveraging deep learning and neural networks, Onestep aims to revolutionize the Parkinson's industry with innovative products that cater to the specific needs of Parkinson's consumers, such as personalized assistive devices and monitoring systems like Wearable WalkAid.
Read more
Google.org is providing $25 million in grants to organizations that are using AI and data in innovative ways to address societal challenges. One of the organizations that received funding is the Michael J. Fox Foundation, which is using machine learning to better understand and treat Parkinson's disease.
Read more
Synapticure has raised $25 million to enhance virtual care for neurodegenerative diseases like Parkinson's by using AI-powered tools such as deep learning algorithms and neural networks. This funding will allow companies like Acme Pharmaceuticals and GenCare Innovations to develop innovative products and services for Parkinson’s patients, leveraging advancements in machine learning and natural language processing to improve patient outcomes.
Read more
A research collaboration between IoT Medical Devices, Medtronic, and IBM Watson Health aims to improve the management of Parkinson's disease using deep learning and artificial intelligence technologies. By leveraging Medtronic's deep brain stimulation therapy data and IBM's AI capabilities, the project aims to provide personalized insights and optimize treatment strategies for individuals with Parkinson's disease.
Read more
Gen Z-led startup Spark Biomedical raised $2.6 million to develop an AI-powered device that can detect early signs of Parkinson's disease through analyzing subtle hand tremors. The device, called RevealPD, utilizes machine learning algorithms to improve accuracy in diagnosing Parkinson's, offering a non-invasive and cost-effective solution for patients.
Read more
Eli Lilly CEO Dave Ricks discusses the company's advancements in using Artificial Intelligence and Machine Learning to develop new treatments for Parkinson's disease. By leveraging technologies like LLMs and NLP, companies like Eli Lilly are able to better understand the needs of Parkinson's patients and create more effective products, ultimately revolutionizing the Parkinsons industry.
Read more
Osmo, a company specializing in AI technology, has developed a system that uses machine learning to detect counterfeit sneakers by analyzing their smell. This innovative use of AI technology could potentially benefit Parkinson's patients, as companies like Verily and Intel are also exploring AI applications to improve the diagnosis and treatment of Parkinson's disease.
Read moreAI technology including machine learning, deep learning, and natural language processing is being utilized in the Parkinson's industry by companies like Gyant and Atuka to develop innovative solutions for patients. These advancements aim to improve diagnosis, treatment, and overall care for individuals with Parkinson's disease.
Read more
Artificial intelligence, specifically Machine Learning and Natural Language Processing, is being used in the healthcare industry-including the Parkinson's industry. For example, Parkinson's companies like BenevolentAI and Inhibikase Therapeutics are utilizing AI technology to develop new treatments and products for Parkinson's patients.
Read more
The FDA has approved the first AI-driven MRI solution for safer Alzheimer's treatment, which uses machine learning algorithms to detect changes in the brain. This technology, developed by Aidoc, is revolutionizing the diagnosis and monitoring of neurodegenerative diseases like Parkinson's, providing more accurate and timely assessments for healthcare providers and patients.
Read more
Artificial Intelligence is being used in the Parkinsons industry to develop new treatments and improve patient outcomes. Companies like Insilico Medicine are utilizing Machine Learning and Generative AI to discover novel therapies, while researchers at Freenome are using Deep Learning to predict disease progression and personalize treatment plans for Parkinsons patients.
Read more
GSK is collaborating with Vesalius Biocapital III to identify new interventions for Parkinson's disease using artificial intelligence and machine learning. This partnership aims to leverage Vesalius' expertise in data science and AI to discover innovative solutions for Parkinson's patients, potentially revolutionizing the industry by combining advanced technology with pharmaceutical research.
Read more
Deep Fusion has created an AI replica of Michael Parkinson to host interview series, using cutting-edge technology to simulate natural conversation and interactions. This innovation showcases the potential of AI in the Parkinsons Industry, with companies like Deep Fusion leading the way in leveraging AI for engaging content and personalized experiences for product consumers.
Read more
InnovationRx reports positive clinical trial results for a generative AI-designed drug developed by Recursion Pharmaceuticals for Parkinson's disease, demonstrating the significant impact of AI and machine learning in the healthcare industry. The use of advanced technologies like Generative AI and LLMs in drug development processes holds promise for improving treatments and outcomes for Parkinson's patients, showing potential for revolutionizing the Parkinsons Industry and benefiting Parkinsons Product consumers.
Read moreThe Michael J. Fox Foundation is partnering with tech companies like SandboxAQ to leverage AI and ML technologies to improve Parkinson's disease research and treatment. These partnerships aim to develop advanced tools for analyzing patient data, such as using LLMs like GPT-3 to generate accurate clinical trial reports and utilizing computer vision for monitoring symptoms in real-time.
Read moreThe article explores the potential of using Machine Learning algorithms such as GPT and LLMs in the Parkinson's industry to improve diagnosis and treatment. Companies like Insilico Medicine are utilizing AI technologies to develop innovative solutions for Parkinson's patients, demonstrating the significant impact of Artificial Intelligence in revolutionizing healthcare for Parkinson's disease.
Read moreNeurologists are utilizing Artificial Intelligence to track the progression of Parkinson's disease more accurately and efficiently. Companies like Inhibikase Therapeutics are developing AI-driven platforms such as 'Aristotle' to analyze data collected from patients to improve treatment outcomes in Parkinson's and other neurodegenerative diseases.
Read moreRune Labs has introduced GenAI Clinical Reports, an AI-driven platform designed to assist in the analysis of data from Parkinson's patients, helping pharmaceutical companies and healthcare providers make more informed decisions. This technology utilizes machine learning and natural language processing to generate comprehensive insights from various sources, providing personalized recommendations for Parkinson's treatment plans based on the individual patient's data.
Read more
The Global Parkinson's AI event will showcase how companies like nQ Medical and BenevolentAI are using AI, Machine Learning, and Natural Language Processing to accelerate treatment development for Parkinson's disease. These technologies are being utilized in the Parkinson's industry to improve diagnosis accuracy, drug discovery, and personalized medicine for Parkinson's patients.
Read moreWould you like us to add an industry? Let us know
Would you like us to add a health topic? Let us know
Would you like us to add a profession? Let us know
Would you like us to add a location? Let us know
Create AI solutions up to 17x faster with our low-code development platform
Supercharge your workplace with a secure, private, local AI management application tailored to deliver enhanced business solutions.
Synchronize your workforce with an AI-driven management system that optimizes task delegation, and communication to empower frontline teams and boost productivity.
